XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:              
Net loss $ (1,234,986) $ (4,532,363) $ (5,988,423) $ (2,267,908) $ (6,522,441) $ (9,510,360)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation         112,174 93,737  
Unrealized loss on marketable securities         595,783 9,903  
Stock based compensation expense         1,871,386 1,297,384  
Goodwill impairment charge 0   3,392,129   0 3,392,129 $ 5,098,784
Changes in assets and liabilities:              
Accounts receivable         (398,297) 449,322  
Inventory         127,372 (1,210,921)  
Inventory deposits         443,074 1,696,180  
Prepaid expenses         (112,390) 3,190  
Other assets         232,102 (112,382)  
Accounts payable         317,456 90,272  
Accrued liabilities         700,014 (238,030)  
Other liabilities         (215,109) 0  
Net cash used in operating activities         (2,848,876) (4,039,576)  
Cash flows from investing activities:              
Purchase of property and equipment         (229,029) (36,331)  
Sale of marketable securities         0 2,342,643  
Net cash (used in) provided by investing activities         (229,029) 2,306,312  
Cash flows from financing activities:              
Proceeds from issuance of common stock         1,799,248 0  
Proceeds from issuance of convertible note         901,000 0  
Proceeds from related party loan         300,000 0  
Proceeds from debt         648,937 0  
Principal repayments on debt         (345,345) (213,161)  
Net cash provided by (used in) by financing activities         3,303,840 (213,161)  
Net change in cash, restricted cash and cash equivalents         225,935 (1,946,425)  
Cash and cash equivalents at the beginning of the period   $ 456,719   $ 2,825,467 456,719 2,825,467 2,825,467
Cash and cash equivalents at the end of the period $ 682,654   $ 879,042   682,654 879,042 $ 456,719
Supplemental cash flow disclosures:              
Cash paid for interest expense         14,623 5,808  
Non-cash common stock issued for services         0 1  
Stock issued for equity line of credit commitment fees         125,000 0  
Cancellation of Convertible note cancelled and transferred to Notes payable - current         1,025,743 0  
Conversion of short-term note to common stock         1,046,259 0  
Capital expenditures unpaid on September 30, 2024         $ 4,187 $ 0